Cannabis and psychosis

The Lancet Psychiatry

Volumn 2, Issue 5, 2015, Pages 381-382

  Crow, Timothy J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CANNABINOID;

ARMY; CANNABIS USE; DISEASE DURATION; FOLLOW UP; HUMAN; LETTER; ONSET AGE; PERSONALITY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SWEDEN; CANNABIS ADDICTION;

CANNABINOIDS; CANNABIS; HUMANS; MARIJUANA ABUSE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84933525110     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00167-4     Document Type: Letter

References (2)

1. Andreasson S, Engstrom A, Allebeck P, Rydberg U Cannabis and schizophrenia-a longitudinal study of Swedish conscripts. Lancet 1987, 330:1483-1486.
2. Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2015, 2:233-238.